Womb for sale debate surfaces in Nepal
By Times of India,
The Times of India [Nepal]
| 03. 08. 2011
Almost nine years after India's Supreme Court gave the legal nod to commercial surrogacy, the issue has finally surfaced in Nepal after a disgruntled wife went to court to prevent her husband from bequeathing his property to his daughter by a surrogate mother.
Sambhavi Rana, who comes from an upper class family in Kathmandu, and her mother-in-law Vidya Rana, went to Supreme Court to stop the former's husband, Ujjwal Rana, from bequeathing the couple's property to his three-year-old daughter Bina. Bina had been conceived by a commercial surrogate mother, Ayushma Nagarkoti, with whom Rana had signed a formal contract, undertaking to pay maintenance and medical costs for her for two years and the woman had agreed to hand over the child when she was two.
Though Rana had also notified the chief district officer, saying his wife, who was incapable of giving birth, had agreed to the contract, the wife challenged it in court, saying she was kept in the dark. She also challenged his claim that she could not conceive, accusing him of mental and other forms of cruelty...
Related Articles
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Gabriele Pichlhofer and Tino Plümecke, Guest Contributors
| 03.25.2026
A German translation of this interview will be published in May 2026 in the German GID MAGAZIN, which focuses on the market for reproductive technologies. For more information, visit: Gen-ethisches Netzwerk
Egg donation is currently prohibited in Germany and Switzerland, but both countries have been debating its legalization for years. In Switzerland, a legal framework is currently being developed, with a first draft expected by the end of the year. Yet the debate rarely draws on scientific evidence. Instead...
By Charles Pulliam-Moore, The Verge | 03.21.2026
Like many people, director Valerie Veatch was intrigued when OpenAI first released its Sora text-to-video generative AI model to the public in 2024. Though she didn’t fully understand the technology, she was curious about what it could do, and she...
By Ritsuko Kawai, Wired | 03.14.2026
On March 6, Japan’s Ministry of Health, Labor and Welfare officially granted conditional and time-limited marketing authorization to two regenerative medical products derived from reprogrammed iPS cells, marking exactly 20 years since the creation of mouse iPS cells.These will...